Jump Start on the Go: Improving Resiliency and the Social-Emotional Development of At-Risk Preschool Children
Conditions: Mental Health Wellness 1 Interventions: Behavioral: Jump Start on the Go; Behavioral: Jump Start Plus Coronavirus Support Sponsors: University of Miami Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Radiological Characterization of Pulmonary Involvement in Patients With Hematological Diseases
Conditions: Hematologic Diseases Interventions: Diagnostic Test: Complete Blood Count; Diagnostic Test: C-reactive protein; Diagnostic Test: O2 saturation; Diagnostic Test: Serum ferritin and D-dimer; Diagnostic Test: Liver and renal function tests; Diagnostic Test: Lactate dehydrogenase; Diagnostic Test: coronavirus (SARS-CoV-2) swab; Radiation: CT chest Sponsors: New Valley University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)
Conditions: Long COVID; Long Coronavirus Disease 2019 (Covid19); Long Covid-19 Interventions: Drug: IVIG (intravenous immunoglobulin); Drug: IVIG Placebo; Behavioral: Coordinated Care; Behavioral: Usual Care Sponsors: Duke University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 12, 2024 Category: Research Source Type: clinical trials
Evaluation of KGR Prescriptions in Suppressing COVID-19 Infection.
Conditions: Coronavirus Disease 2019; Severe Acute Respiratory Syndrome Coronavirus 2 Infection Interventions: Combination Product: Kang Guan Recipe (Treat); Combination Product: Kang Guan Recipe (Placebo) Sponsors: Sheng-Teng Huang Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Cyclo-Ergometry in the Patient With Acute Respiratory Distress Syndrome
Conditions: Coronavirus Interventions: Other: Bed cyclo-ergonometry; Other: Bed mobility activities (turning, pelvic elevation and sitting), standing, transfers and walking.; Other: Progressive upper and lower limb strength training Sponsors: Biogipuzkoa Health Research Institute Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2024 Category: Research Source Type: clinical trials
Thrombohemorrhagic Complications of COVID-19
Conditions: COVID-19 (Coronavirus Disease 2019) Interventions: Diagnostic Test: Prevention algorithm Sponsors: Volgograd State Medical University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Efficacy and safety of azvudine in symptomatic adult COVID-19 participants who are at increased risk of progressing to critical illness: a study protocol for a multicentre randomized double-blind placebo-controlled phase III trial
DiscussionThe purpose of this clinical trial is to determine whether azvudine can prevent patients at risk of severe disease from progressing to critical illness and death, and the results will identify whether azvudine is an effective and affordable antiviral treatment option for COVID-19.Trial registrationClinicalTrials.gov NCT05689034. Registered on 18 January 2023. (Source: Trials)
Source: Trials - January 22, 2024 Category: Research Source Type: clinical trials
To Investigate the Effect of 2019 Novel Coronavirus Infection on the Condition of Patients With Hyperthyroidism
Conditions: Hyperthyroidism; COVID-19 Interventions: Other: Thyroid metabolic index Sponsors: Qilu Hospital of Shandong University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2024 Category: Research Source Type: clinical trials
Immunogenicity After COVID-19 Vaccines in Adapted Schedules
Conditions: Coronavirus Disease 2019; COVID-19 Interventions: Drug: BNT162b2 30 µg; Drug: BNT162b2 20µg; Drug: BNT162b2 6µg; Drug: mRNA-1273 100µg; Drug: mRNA-1273 50µg; Drug: ChAdOx1-S [Recombinant] Sponsors: Universiteit Antwerpen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
STREngthening COronavirus Disease 2019 (COVID-19) Surveillance in Africa
Conditions: COVID-19; SARS CoV 2 Infection; COVID-19 Pandemic Sponsors: Institut de Recherche pour le Developpement; European and Developing Countries Clinical Trials Partnership (EDCTP); Institut de Recherche Clinique du B énin; Barcelona Institute for Global Health; Ministère de la Santé - Bénin; Ministère de la Santé et de Hygiène Publique - Burkina Faso Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza.
Conditions: COVID-19; Coronavirus Disease 2019; Influenza Interventions: Biological: COVID-19 Vaccine Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Severe Acute Respiratory Syndrome Coronavirus 2 Re-Infection Risk and Vaccine Efficacy in Austria
Conditions: COVID-19 Interventions: Biological: Vaccination against SARS-CoV-2 Sponsors: Medical University of Graz; AGES; Medical University Innsbruck; Austrian Science Fund (FWF) Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
Xofluza-Wearables Feasibility-Study
Conditions: Infection, Coronavirus; Infections; Influenza; Transplant; Infection Viral Interventions: Drug: Baloxavir Marboxil Sponsors: Children ' s Hospital of Philadelphia; Genentech, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial
DiscussionThis paper provides a comprehensive description of the statistical analysis plan in order to ensure the reproducibility of the analysis and avoid selective reporting of outcomes and data-driven analysis. Sensitivity analyses have been included in the protocol to assess the impact of intercurrent events related to the coronavirus disease 2019. By focusing on clinically meaningful and robust outcomes, this trial aims to determine whether TUDCA can be effective in slowing the disease progression in patients with ALS.Trial registrationClinicalTrials.govNCT03800524. Registered on January 11, 2019. (Source: Trials)
Source: Trials - December 5, 2023 Category: Research Source Type: clinical trials
First-in-human Study to Evaluate the Safety and Immunogenicity of Three Dose Levels of the OVX033 Coronavirus Vaccine Candidate in Healthy Volunteers
Conditions: Coronavirus Interventions: Biological: OVX033; Biological: Saline solution Sponsors: Osivax; Centre for the Evaluation of Vaccination H ôpital Cochin Assistance Publique - Hôpitaux de Paris (APHP) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
